 | Up a level |
Fix, Michael K; Frei, Daniel; Volken, Werner; Born, Ernst J; Aebersold, Daniel M; Manser, Peter (2013). Macro Monte Carlo for dose calculation of proton beams. Physics in medicine and biology, 58(7), pp. 2027-44. Bristol: Institute of Physics Publishing IOP 10.1088/0031-9155/58/7/2027
Medová, Michaela; Aebersold, Daniel M; Zimmer, Yitzhak (2012). MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks. International journal of cancer, 130(3), pp. 728-34. Malden, Mass.: Wiley-Blackwell 10.1002/ijc.26058
Ghadjar, Pirus; Simcock, Mathew; Studer, Gabriela; Allal, Abdelkarim S; Ozsahin, Mahmut; Bernier, Jacques; Töpfer, Michael; Zimmermann, Frank; Betz, Michael; Glanzmann, Christoph; Aebersold, Daniel M (2012). Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: 10-Year Follow-up of a Randomized Phase III Trial (SAKK 10/94). International journal of radiation oncology, biology, physics, 82(2), pp. 524-31. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2010.07.105
Ghadjar, Pirus; Bojaxhiu, Beat; Simcock, Mathew; Terribilini, Dario; Isaak, Bernhard; Gut, Philipp; Wolfensberger, Patrick; Brömme, Jens O; Geretschläger, Andreas; Behrensmeier, Frank; Pica, Alessia; Aebersold, Daniel M (2012). High Dose-Rate Versus Low Dose-Rate Brachytherapy for Lip Cancer. International journal of radiation oncology, biology, physics, 83(4), pp. 1205-12. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2011.09.038
Ghadjar, Pirus; Aebersold, Daniel M (2012). Re: andrew j. Stephenson, michel bolla, alberto briganti, et Al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur urol 2012;61:443-51. European urology, 61(4), e39. Amsterdam: Elsevier 10.1016/j.eururo.2011.11.054
Ghadjar, Pirus; Simcock, Mathew; Zimmermann, Frank; Betz, Michael; Bodis, Stephan; Bernier, Jacques; Studer, Gabriela; Aebersold, Daniel M; Swiss Group for Clinical Cancer Research (SAKK), (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and oncology, 104(2), pp. 213-8. Amsterdam: Elsevier 10.1016/j.radonc.2012.05.004
Rothschild, Sacha; Bucher, Stephan E; Bernier, Jacques; Aebersold, Daniel M; Zouhair, Aberrahim; Ries, Gerhard; Lombrieser, Norbert; Lippuner, Thomas; Lütolf, Urs M; Glanzmann, Christoph; Ciernik, I Frank (2011). Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial. International journal of radiation oncology, biology, physics, 80(1), pp. 126-32. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2010.01.048
Ghadjar, Pirus; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Thalmann, George N; Aebersold, Daniel M (2011). Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Brachytherapy, 10(4), pp. 286-94. New York, N.Y.: Elsevier
Ghadjar, Pirus; Kaanders, Johannes H; Poortmans, Philipp; Zaucha, Renata; Krengli, Marco; Lagrange, Jean L; Özsoy, Orhan; Nguyen, Tan D; Miralbell, Raymond; Baize, Adele; Boujelbene, Noureddine; Collen, Timothy; Scandolaro, Luciano; Untereiner, Michel; Goldberg, Hadassah; Pesce, Gianfranco A; Anacak, Yavuz; Friedrich, Esther E; Aebersold, Daniel M and Beer, Karl T (2011). The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. International journal of radiation oncology, biology, physics, 81(4), e583-91. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2004.07.565
Zimmer, Yitzhak; Vaseva, Angelina V; Medová, Michaela; Streit, Bruno; Blank-Liss, Wieslawa; Greiner, Richard H; Schiering, Nikolaus; Aebersold, Daniel M (2010). Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274. Cancer letters, 289(2), pp. 228-36. Amsterdam: Elsevier 10.1016/j.canlet.2009.08.017
Ghadjar, Pirus; Schreiber-Facklam, Heide; Gräter, Ruth; Evers, Christina; Simcock, Mathew; Geretschläger, Andreas; Blumstein, Norbert M; Zbären, Peter; Zimmer, Yitzhak; Wilkens, Ludwig; Aebersold, Daniel M (2010). Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. International journal of radiation oncology, biology, physics, 76(4), pp. 1127-32. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2009.03.065
Niyazi, Maximilian; Caversaccio, Marco-Domenico; Dubach, Patrick; Geretschläger, Andreas; Arnold, Andreas; Belka, Claus; Aebersold, Daniel M; Blumstein, Norbert M (2010). Intensity-modulated radiotherapy for a rendu-osler-weber disease patient with recurrent severe epistaxis: a case report. Case reports in medicine, 2010, p. 321835. New York, N.Y.: Hindawi Publishing Corporation 10.1155/2010/321835
Ghadjar, Pirus; Simcock, Mathew; Schreiber-Facklam, Heide; Zimmer, Yitzhak; Gräter, Ruth; Evers, Christina; Arnold, Andreas; Wilkens, Ludwig; Aebersold, Daniel M (2010). Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinoma. International journal of radiation oncology, biology, physics, 78(5), pp. 1366-72. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2009.07.411
Ghadjar, Pirus; Joos, Daniela; Martinelli, Michele; Hullin, Roger; Zwahlen, Marcel; Lössl, Kristina; Carrel, Thierry; Aebersold, Daniel M; Mohacsi, Paul (2010). Tailored total lymphoid irradiation in heart transplant patients: 10-years experience of one center. Radiation oncology, 5, p. 3. London: BioMed Central 10.1186/1748-717X-5-3
Ghadjar, Pirus; Gwerder, Nicole; Manser, Peter; Vock, Jacqueline; Madlung, Axel; Mini, Roberto; Aebersold, Daniel M (2010). High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer. Strahlentherapie und Onkologie, 186(12), pp. 687-92. Heidelberg: Urban and Vogel 10.1007/s00066-010-2180-8
Bekkering, Geertruida E; Rutjes, Anne W S; Vlassov, Vasiliy V; Aebersold, Daniel M; von Bremen, Konrade; Jüni, Peter; Kleijnen, Jos (2009). The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review. Strahlentherapie und Onkologie, 185(4), pp. 211-21. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-009-1900-4
Vastardis, Iraklis; Pajic, Bojan; Greiner, Richard H; Pajic-Eggspuehler, Brigitte; Aebersold, Daniel M (2009). Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up. Strahlentherapie und Onkologie, 185(12), pp. 808-14. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-009-2000-1
Ghadjar, Pirus; Gwerder, Nicole; Madlung, Axel; Behrensmeier, Frank; Thalmann, George N; Mini, Roberto; Aebersold, Daniel M (2009). Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer. Strahlentherapie und Onkologie, 185(11), pp. 731-5. Heidelberg: Urban and Vogel 10.1007/s00066-009-2007-7
Ghadjar, Pirus; Blank-Liss, Wieslawa; Simcock, Mathew; Hegyi, Ivan; Beer, Karl T; Moch, Holger; Aebersold, Daniel M; Zimmer, Yitzhak (2009). MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical & experimental metastasis, 26(7), pp. 809-15. Dordrecht: Springer Netherlands 10.1007/s10585-009-9280-9
Ghadjar, Pirus; Rubie, Claudia; Aebersold, Daniel M; Keilholz, Ulrich (2009). The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. International journal of cancer, 125(4), pp. 741-5. Malden, Mass.: Wiley-Blackwell 10.1002/ijc.24468
Ghadjar, Pirus; Matzinger, Oscar; Isaak, Bernhard; Behrensmeier, Frank; Stroux, Andrea; Rentsch, Cyrill A; Thalmann, George N; Aebersold, Daniel M (2009). Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Radiotherapy and oncology, 91(2), pp. 237-42. Amsterdam: Elsevier 10.1016/j.radonc.2008.12.007
Ghadjar, Pirus; Keller, Tamara; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Stroux, Andrea; Thalmann, George N; Aebersold, Daniel M (2009). Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy, 8(1), pp. 45-51. New York, N.Y.: Elsevier 10.1016/j.brachy.2008.09.004
Ghadjar, Pirus; Vock, Jacqueline; Vetterli, Daniel; Manser, Peter; Bigler, Roland; Tille, Jan; Madlung, Axel; Behrensmeier, Frank; Mini, Roberto; Aebersold, Daniel M (2008). Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking. Radiation oncology, 3, p. 35. London: BioMed Central 10.1186/1748-717X-3-35
Ganapathipillai, Suganthini S; Medová, Michaela; Aebersold, Daniel M; Manley, Paul W; Berthou, Sylvie; Streit, Bruno; Blank-Liss, Wieslawa; Greiner, Richard H; Rothen-Rutishauser, Barbara; Zimmer, Yitzhak (2008). Coupling of mutated Met variants to DNA repair via Abl and Rad51. Cancer research, 68(14), pp. 5769-77. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-08-1269
Vetterli, Daniel; Thalmann, Sandrine; Behrensmeier, Frank; Kemmerling, Ludger; Born, Ernst J; Mini, Roberto; Greiner, Richard H; Aebersold, Daniel M (2006). Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode. Radiotherapy and oncology, 79(1), pp. 101-8. Amsterdam: Elsevier 10.1016/j.radonc.2006.03.005
Djonov, Valentin; Cresto, Nicola; Aebersold, Daniel M; Burri, Peter H.; Altermatt, Hans Jörg; Hristic, Miriana; Berclaz, Gilles; Ziemiecki, Andrew; Andres, Anne-Catherine (2002). Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. International journal of oncology, 21(1), pp. 25-30. Spandidos Publications 10.3892/ijo.21.1.25
